BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35761328)

  • 1. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Jordan V
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
    Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery versus medical therapy for heavy menstrual bleeding.
    Marjoribanks J; Lethaby A; Farquhar C
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
    Papadakis EP; El-Nashar SA; Laughlin-Tommaso SK; Shazly SA; Hopkins MR; Breitkopf DM; Famuyide AO
    J Minim Invasive Gynecol; 2015; 22(7):1203-7. PubMed ID: 26122898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
    Huijs DPC; Derickx AJM; Beelen P; Leemans JC; van Kuijk SMJ; Bongers MY; Geomini PMAJ
    Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of endometrial ablation or resection and levonorgestrel-releasing intrauterine system in women with heavy menstrual bleeding: A systematic review.
    Oderkerk TJ; van de Kar MMA; van der Zanden CHM; Geomini PMAJ; Herman MC; Bongers MY
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1779-1787. PubMed ID: 34165779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
    Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
    Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.
    Herman MC; van den Brink MJ; Geomini PM; van Meurs HS; Huirne JA; Eising HP; Timmermans A; Pijnenborg JM; Klinkert ER; Coppus SF; Nieboer TE; Catshoek R; van der Voet LF; van Eijndhoven HW; Graziosi GC; Veersema S; van Kesteren PJ; Langenveld J; Smeets NA; van Vliet HA; van der Steeg JW; Lisman-van Leeuwen Y; Dekker JH; Mol BW; Berger MY; Bongers MY
    BMC Womens Health; 2013 Aug; 13():32. PubMed ID: 23927387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.
    Kai J; Dutton B; Vinogradova Y; Hilken N; Gupta J; Daniels J
    Health Technol Assess; 2023 Oct; 27(17):1-50. PubMed ID: 37924269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of treatments for heavy menstrual bleeding.
    Spencer JC; Louie M; Moulder JK; Ellis V; Schiff LD; Toubia T; Siedhoff MT; Wheeler SB
    Am J Obstet Gynecol; 2017 Nov; 217(5):574.e1-574.e9. PubMed ID: 28754438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.
    van den Brink MJ; Beelen P; Herman MC; Geomini PM; Dekker JH; Vermeulen KM; Bongers MY; Berger MY
    BJOG; 2021 Nov; 128(12):2003-2011. PubMed ID: 34245652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
    Silva-Filho AL; Pereira Fde A; de Souza SS; Loures LF; Rocha AP; Valadares CN; Carneiro MM; Tavares RL; Camargos AF
    Contraception; 2013 Apr; 87(4):409-15. PubMed ID: 23228505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.